From aidsmap.com:
A CRISPR-based gene-editing therapy known as EBT-101 was not associated with serious adverse effects in the first three treated study participants, researchers reported last week at the European Society for Gene & Cell Therapy annual meeting in Brussels. The presentation, however, was devoid of any data about whether the treatment works to control HIV.
That didn’t stop the Daily Mail from proclaiming that a cure for HIV “could be months away” – just the latest in a string of media reports exaggerating the state of functional cure research.
